Product Search for novus: Novus Biologicals

Novus Biologicals products are now on bio-techne.com

Sort By:

Products (4)

page of 1

4 Results for "novus"

NBP1-21502

Ferroportin/SLC40A1 Antibody - BSA Free

(7 Reviews)

(168 Publications)

0.1 ml

NBP1-21502

$Mouse Ferroportin/SLC40A1, 5-aminolevulinic acid synthase (ALAS), and ferritin light chain (FLC) proteins are increased in sickle mice overexpressing human wt-FHC. Proteins of subcellular fractions isolated from livers of wt-, ms-, and LRS-treated mice (n = 4) were run on a western blot (30 ug protein/lane) and immunostained for microsomal ferroportin. Image collected and cropped by CiteAb from the following publication (//journal.frontiersin.org/article/10.3389/fphar.2014.00079/abstract), licensed under a CC-BY license.$

HepG2 cells were fixed and permeabilized for 10 minutes using -20C MeOH. The cells were incubated with Ferroportin/SLC40A1 Antibody at 5.0 ug/ml overnight at 4C and detected with an anti-rabbit DyLight 488 (green) at a 1:500 dilution. Alpha tubulin (DM1A) [NB100-690] was used as a co-stain at a 1:1000 dilution and detected with an anti-mouse DyLight 550 (red) at a 1:500 dilution. Nuclei were counterstained with DAPI (blue). Cells were imaged using a 40X objective.

Detection of Ferroportin/SLC40A1 protein in murine small intestinal section using Ferroportin/SLC40A1 Antibody at a dilution of 1:200. The antibody primarily developed a membranous staining pattern in the intestinal epithelial cells.

An intracellular stain was performed on HepG2 cells with Ferroportin/SLC40A1 Antibody NBP1-21502 (blue) and a matched isotype control NBP2-24891 (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550 (SA5-10033, Thermo Fisher).

Western blot of human intestine lysate (Molecular weight: 62.5 KDa) using Ferroportin/SLC40A1 Antibody.

Western blot of bovine adult eye using Ferroportin/SLC40A1 Antibody. Image from verified customer review.

Duodenal mucosa samples from weanling pigs with iron replete or iron deficient status were probed using (NBP1-21502; 1:1000 dilution) and GAPDH (loading control). Image from verified customer review.

HepG2 clones overexpressing heparanase showed a reduction of hepcidin expression and indices of iron loading. Two stable clones of HepG2 cells transfected with pcDNA3.1-HPA (HPA3 and HPA6) were analyzed for hepcidin expression, BMP/SMAD signaling and indices of iron status. Western blot of Ferroportin/SLC40A1 and its densitometry. The values are expressed as-dCt (for HPA mRNA) or as fold change over the control (MOCK) (for hepcidin and Id1 mRNA). The images are representative from three different analyses. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371:journal.pone.0164183), licensed under a CC-BY license.

Immunostaining for Ferroportin/SLC40A1 shows uniform reactivity on the ciliary epithelium (panel 1). Fpn is expressed mainly in NPE cells (panel 2). H&E stained section shows orientation of the ciliary epithelium with respect to the iris and AH (panel 3). Fpn is expressed on corneal epithelium (panel 4) and endothelium (panel 5). Scale bar: 25 um. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/29859760/) licensed under a CC-BY license.

Detection of Ferroportin/SLC40A1 protein in murine liver section using Ferroportin/SLC40A1 Antibody at a dilution of 1:200. The representative image shows intense staining in the cellular membranes, whereas, a relatively milder postivity was observed in the cytoplasm of hepatocytes.

Analysis using the PE conjugate of Ferroportin/SLC40A1 Antibody. Staining of Ferroportin in human B lymphocytes in peripheral blood using PE conjugated anti-Ferroportin/SLC40A1 antibody. Image from verified customer review.

An intracellular stain was performed on HepG2 cells with NBP1-21502AF647 (blue) and a matched isotype control (orange, NBP2-24893AF647). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 647.

An intracellular stain was performed on Hek293 cells with NBP1-21502 (blue) and a matched isotype control NBP2-24891 (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550 (SA5-10033, Thermo Fisher).

$Mouse ferroportin, 5-aminolevulinic acid synthase (ALAS), and ferritin light chain (FLC) proteins are increased in sickle mice overexpressing human wt-FHC. Proteins of subcellular fractions isolated from livers of wt-, ms-, and LRS-treated mice (n = 4) were run on a western blot (30 ug protein/lane) and immunostained for (A) microsomal ferroportin.$

Htt elimination disrupts brain iron homeostasis. (B) Representative western blots of Tfr and Fpn protein expression in 10 month-old brains from CTL and cKO mice TM-treated at 6 months of age. Antibody against actin was used as internal control for loading. Note that Tfr and Fpn levels are increased in TM-treated cKO compared to controls. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pgen.1006846), licensed under a CC-BY licence.

Inhibition of GLRX5 upregulates an iron-starvation response. (A-D) Protein and mRNA expression of (TfR1, TFRC), iron regulatory protein (IRP2, IREB2), ferritin (FTH1) and ferroportin (Fpn, SLC40A1) genes in HN4R cells stably transduced with a vector or shGLRX5 and GLRX5res, which were subjected to 1 mM SAS treatment for 24 h. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32685019), licensed under a CC-BY licence.

Neratinib induces cell death by ferroptosis.f, g) Lysates from control, neratinib or neratinib + liproxstatin-treated cells were analysed for the expression of ACSL4, ferritin, ferroportin-1 and transferrin receptor-1. A representative blot from three experiments is shown in f and quantitation relative toGAPDH (n = 3) shown in g. *p < 0.05, **p < 0.01. h ICP-MS analysis of iron content in control and inhibitor-treated TBCP-1 cells. Data are expressed as ng/106 cells and show mean +/- SD of six replicate samples. **p < 0.01 Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31409375), licensed under a CC-BY licence.

Effects of HDAC3 inhibition in vivo on hepcidin expression in iron-deficient mice. H) Western blot for hepatic ferroportin expression. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/28864822), licensed under a CC-BY licence.

$Differential expression of proteins of iron metabolism in CCA cells. The CCA4, CCLP1 and HUCCT1 human CCA-derived cell lines were cultured as adherent monolayers (MON) or in 3D sphere conditions (SPH). Panel a. Top left, representative immunoblot analysis. Cell extracts were reacted with antibodies against transferrin receptor (TfR1), ferroportin (FPN), ferritin H subunit (FtH) and vinculin. Cropped blots are displayed. The original full blot images can be found in Supplementary Information. The graphs show densitometric quantification of immunoblot analyses. The values were normalized to vinculin and expressed as a fraction of respective MON cells normalized to 1. Mean values +/- SEM (n = 6), *p <= 0.05, **p <= 0.01 vs control MON for each cell line. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/29247214), licensed under a CC-BY licence.$

EBNA1 promotes the upregulation of oxidative DNA damage repair pathways in EBV converted cell lines and EBV positive BLs. a Representative western blots illustrating the expression of MTH1, OGG1, and MUTYH in pairs of EBV-negative and -positive cell lines. GAPDH was used as loading control. b Densitometry quantification of the specific bands. The intensity of the specific band in EBV positive cells relative the EBV-negative parental is shown. Mean ± SE of four independent experiments. c Representative western blots illustrating the expression of EBNA1, MTH1, OGG1, and MUTYH in the Mutu cell lines. d Densitometry quantification of expression in the EBV positive cell lines relative to the EBV-negative Mutu-30. Mean ± SE of four independent experiments Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/31511648), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

NDRG2 decreases the glucose uptake and GLUT1 protein levels in SK-BR-3-based subcutaneously xenograft tumours. The experiments illustrated are described in the Methods section. (A) Tumour growth was assessed every 3 days until day 21 treatment by measuring two perpendicular diameters and calculating the volume in cubic centimetres. Ad-LacZ, adenovirus expressing LacZ; Ad-NDRG2, adenovirus expressing NDRG2; PFU, Plaque-forming units. The data presented are means ± SD; error bars represent SD from 6 mice. *P < 0.05 and **P < 0.01 versus phosphate-buffered saline (PBS) or Ad-LacZ. (B) Tumour cells were dissociated from xenograft tumours and suspended in PBS after the number of cells was counted. Next, the glucose uptake of cells in each group was detected. The data presented are means ± SD of three independent experiments; error bars represent SD from 6 mice. *P < 0.05 and **P < 0.01 versus PBS or Ad-LacZ. (C) Intratumoural protein expression was assessed by N-myc downstream-regulated gene 2 (NDRG2) and glucose transporter 1 (GLUT1) IHC staining. Representative images are shown. Original magnification: 400 x; Scale bars = 50 μm. (D) Proteins of the xenograft tumours from each group were extracted and analysed by immunoblotting to quantify NDRG2 and GLUT1 protein changes. Image collected and cropped by CiteAb from the following open publication (//breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3628), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

a Heatmap of regulated genes related to phagocytosis in the corpus callosum (CC), cerebellum (Cb) and cortex (Cx) at different ages [postnatal day (P)7, 10, 42]. b Heatmap of known priming genes in the CC, Cb and Cx at P7, P10 and P42. Asterisks highlighting genes confirmed on protein level; Representative immunofluorescence pictures of wildtype mice depicting SPP1 [red (c, e)], CLEC7a [white (c, e)] and CD206 [white (d)] expression in IBA-1+ microglia (green) in the CC (c, d), Cx (e left) and Cb (e right) at P7, P10 and P42. Scale bar 50 µm; blue = DAPI; arrow indicating IBA-1+/SPP1+ cell in Cb; N = 3–4 mice per timepoint Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/31262353), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

DEC1 expression decreases in HeLa cells under apoptosis. (A) Endogenous DEC1 protein expressions in HeLa and SiHa cells. Western blotting images of beta -catenin, DEC1, DEC2, SOX2, c-MYC and actin in HeLa and SiHa cells. The western blot analysis was repeated three times and similar results were obtained. (B) Cell viability of HeLa and SiHa cells with (+) or without (−) cisplatin treatment was determined. The absorbance (OD480/OD650) at 0 and 24 h is shown. The value of cell viability of control 0 h regarded as 10, which means each basal value without treatment. Data are expressed as mean values ± SE (bars) of three independent samples. * p <0.01, as determined using Dunnett’s test. Cis: Cisplatin treatment. (C) Western blotting images of cleaved-poly (ADP-ribose) polymerase (PARP), cleaved-caspase 3, Bcl-2, DEC1, DEC2, SOX2, c-MYC and actin treated with 10, 20, and 50 μM cisplatin or mock in HeLa and SiHa cells. The western blot analysis was repeated three times and similar results were obtained (D) DEC1, DEC2 and SOX2 mRNA expressions in HeLa and SiHa cells with (+) or without (−) cisplatin treatment. Data are expressed as mean values ± SE (bars) of three independent samples. * p < 0.01, as determined using t-test. qPCR was repeated three times and similar results were obtained. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/33089188), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

DFMO decreases the HBV core-associated DNA and the HBc protein levels. (A) Determination of cytotoxicity of HepAD38 and HepG2.2.15 cells treated DFMO measured by the MTS assay. (B) HepAD38 cells were treated with DFMO (50 μM, 100 μM), and the HBV core-associated DNA was extracted 3 days later and measured by Southern blot (upper panel). The levels of HBc and HBs were measured by Western blotting, and capsids levels were determined using a Native gel assay (lower panel) as described above. (C) The levels of HBsAg in supernatant were measured by ELISA assay as described above. (D) HBV 3.5kb RNA levels were measured by real-time RT-PCR. (E) and (F) HepG2.2.15 cells treated with DFMO (50, 100 μM) for 3 days, then the levels of intracellular HBV DNA or HBsAg levels in the supernatant were detected by real-time PCR (E) or ELISA assay (F). (G) DFMO decreased the infection capacity of the HBV particles. HepAD38 cells in the absence of tetracycline were treated with DSMO or DFMO with indicated concentration for 3 days, and the HBV viral particles were then collected and added to the HepG2-NTCP cells. Five days later, the cytoplasmic viral DNA were extracted and measured by real-time PCR. RC, relaxed circular; DL, double stranded linear; SS, single stranded. Experiments were performed in triplicate, and data are represented as means ± SD. Statistical significance was determined by one-way ANOVA with the Tukey post-hoc test (*p < 0.05; ns, not significant). Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/32373551), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Lemongrass extract is dependent on the production of oxidative stress to induce apoptosis(A) MV-4-11, E6-1, and U-937 cells were treated with piperlongumine (PL), LG, or WT with or without the antioxidant NAC for 48 hours. Following treatment, cells were stained for Annexin V and PI. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells positive for Annexin V (green), PI (red), Annexin V and PI (yellow), or negative for both Annexin V and PI (blue). Values are expressed as a mean ± SD from three independent experiments. (B) U-937 and E6-1 cells were treated with H2DCFDA following treatments with paraquat (PQ), LG, or WT with or without the antioxidant NAC for 3 hours. Results were obtained using the image-based cytometry with the Y-axis representative of percent of cells positive for DCF. Values are expressed as a mean ± SD from three independent experiments. (C) MV-4-11, E6-1, and U-937 cells were plated and allowed to incubate overnight. Following overnight incubation, cells were treated for 48 hours with or without NAC. To monitor mitochondria potential cells were incubated with JC-1 for 30 minutes before analysis. Results were obtained using image-based cytometry with the Y-axis representative of percent of cells positive for JC-1 expressed as a mean ± SD from three independent experiments. (D) U-937 micrographs at 48 hours. Top: Fluorescent images of cells without NAC stained with JC-1 (red) and Hoechst (blue) at 400x magnification. Bottom: Fluorescent images of cells with NAC stained with JC-1 (red) and Hoechst (blue) at 400x magnification. Scale bar is 25 microns. Images are representative of three independent experiments. (E) E6-1 cells were treated for 3 hours with LG with or without NAC, lysed, and subjected to SDS-PAGE. Cells were then transferred to a PVDF membrane and probed for the specific proteins. Bands were visualized with a chemiluminescence reagent. Statistical calculations were performed using Two-Way ANOVA multiple comparison for (A) and One-Way ANOVA multiple comparison for (B–C). **p < 0.01 vs. Control, ****p < 0.0001 vs. Control. Image collected and cropped by CiteAb from the following open publication (//www.oncotarget.com/lookup/doi/10.18632/oncotarget.22502), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Immunohistochemistry-Paraffin: Rabbit Polyclonal Ferroportin/SLC40A1 Antibody [NBP1-21502] - Staining of mouse small intestines using Ferroportin/SLC40A1 Antibody. Tissue was fixed in formalin overnight and embedded in paraffin. ~5 micro sections on slides were dehydrated. Antigen retrieval was done using citrate buffer in rice steamer for 20mins. 1 hour blocking without permeabilization. Overnight primary ab incubation was done 1:200 (NBP1-21502) at 4C. 2-hr secondary antibody incubation was at room temp; mounting media with DAPI. Image from a verified customer review.

Reactivity:

Hu, Mu, Rt, Po, Bv

Species Glossary

Reactivity: Hu, Mu, Rt, Po, Bv

Applications:

, , ,

Applications: , , ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	NBP1-21502AF350
Alexa Fluor 405	NBP1-21502AF405
Alexa Fluor 488	NBP1-21502AF488
Alexa Fluor 532	NBP1-21502AF532
Alexa Fluor 594	NBP1-21502AF594
Alexa Fluor 647	NBP1-21502AF647
Alexa Fluor 700	NBP1-21502AF700
Alexa Fluor 750	NBP1-21502AF750
Allophycocyanin	NBP1-21502APC
Allophycocyanin/Cy7	NBP1-21502APCCY7
Biotin	NBP1-21502B
DyLight 350	NBP1-21502UV
DyLight 405	NBP1-21502V
DyLight 488	NBP1-21502G
DyLight 550	NBP1-21502R
DyLight 594	NBP1-21502DL594
DyLight 650	NBP1-21502C
DyLight 680	NBP1-21502FR
DyLight 755	NBP1-21502IR
FITC	NBP1-21502F
HRP	NBP1-21502H
Janelia Fluor 549	NBP1-21502JF549
Janelia Fluor 646	NBP1-21502JF646
PE	NBP1-21502PE
PE/Atto594	NBP1-21502PEATT594
PE/Cy5.5	NBP1-21502PECY55
PE/Cy7	NBP1-21502PECY7
PerCP	NBP1-21502PCP
mFluor Violet 450 SE	NBP1-21502MFV450
mFluor Violet 500 SE	NBP1-21502MFV500
mFluor Violet 610 SE	NBP1-21502MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
BSA Free	NBP1-21502SS

compare

(select up to 3 products from this page to compare)

NBP2-75923

Ferroportin/SLC40A1 Antibody (1308C) - BSA Free

(1 Publication)

0.1 mg

NBP2-75923

Flow Cytometry: Ferroportin/SLC40A1 Antibody (1308C) [NBP2-75923] - HEK293 human embryonic kidney cell line transfected with human Ferroportin/SLC40A1 and eGFP was stained with either (A) Rabbit Anti-Human Ferroportin/SLC40A1 Antibody (1308C) (NBP2-75923) or (B) Rabbit IgG Isotype Control (Catalog # MAB1050) followed by APC-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # F0111).

Immunohistochemistry-Paraffin: Ferroportin/SLC40A1 Antibody (1308C) [NBP2-75923] - Ferroportin/SLC40A1 was detected in immersion fixed paraffin-embedded sections of human liver using Rabbit Anti-Human Ferroportin/SLC40A1 Antibody (1308C) (Catalog # NBP2-75923) at 1 ug/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte(TM) HRP Polymer Antibody (Catalog # VC001). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in Kupffer cells.

Reactivity:

Hu, Mu, Rt

Species Glossary

Reactivity: Hu, Mu, Rt

Applications:

,

Applications: ,

Host:

Rabbit Monoclonal

Host: Rabbit Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	NBP2-75923AF350
Alexa Fluor 405	NBP2-75923AF405
Alexa Fluor 488	NBP2-75923AF488
Alexa Fluor 532	NBP2-75923AF532
Alexa Fluor 594	NBP2-75923AF594
Alexa Fluor 647	NBP2-75923AF647
Alexa Fluor 700	NBP2-75923AF700
Alexa Fluor 750	NBP2-75923AF750
Allophycocyanin	NBP2-75923APC
Allophycocyanin/Cy7	NBP2-75923APCCY7
Biotin	NBP2-75923B
DyLight 350	NBP2-75923UV
DyLight 405	NBP2-75923V
DyLight 488	NBP2-75923G
DyLight 550	NBP2-75923R
DyLight 594	NBP2-75923DL594
DyLight 650	NBP2-75923C
DyLight 680	NBP2-75923FR
DyLight 755	NBP2-75923IR
FITC	NBP2-75923F
HRP	NBP2-75923H
Janelia Fluor 549	NBP2-75923JF549
Janelia Fluor 646	NBP2-75923JF646
PE	NBP2-75923PE
PE/Atto594	NBP2-75923PEATT594
PE/Cy5.5	NBP2-75923PECY55
PE/Cy7	NBP2-75923PECY7
PerCP	NBP2-75923PCP
mFluor Violet 450 SE	NBP2-75923MFV450
mFluor Violet 500 SE	NBP2-75923MFV500
mFluor Violet 610 SE	NBP2-75923MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
BSA Free	NBP2-75923SS
Azide and BSA Free	NBP2-80731

compare

(select up to 3 products from this page to compare)

H00030061-D01P

Ferroportin/SLC40A1 Antibody

(1 Publication)

0.1 mg

H00030061-D01P

Western Blot: Ferroportin/SLC40A1 Antibody [H00030061-D01P] - Analysis of Ferroportin/SLC40A1 expression (Molecular weight: 62.5 KDa) in transfected 293T cell line by polyclonal Ferroportin/SLC40A1 Antibody.Lane 1: Ferroportin/SLC40A1 transfected lysate(62.50 KDa).Lane 2: Non-transfected lysate.

Western Blot: Ferroportin/SLC40A1 Antibody [H00030061-D01P] - Analysis of Ferroportin/SLC40A1 (Molecular weight: 62.5 KDa) expression in A-431 using Ferroportin/SLC40A1 Antibody.

Western Blot: Ferroportin/SLC40A1 Antibody [H00030061-D01P] - Analysis of Ferroportin/SLC40A1 expression (Molecular weight: 62.5 KDa) in human liver using Ferroportin/SLC40A1 Antibody.

Western Blot: Ferroportin/SLC40A1 Antibody [H00030061-D01P] - Analysis of Ferroportin/SLC40A1 expression (Molecular weight: 62.5 KDa) in IMR-32 using Ferroportin/SLC40A1 Antibody.

Reactivity:

Hu

Species Glossary

Reactivity: Hu

Applications:

Applications:

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

NBP1-21502PE

Ferroportin/SLC40A1 Antibody [PE]

(1 Review)

(3 Publications)

0.1 ml

NBP1-21502PE

Analysis of Ferroportin in human B lymphocytes in peripheral blood using PE conjugated anti-Ferroportin antibody. Image from verified customer review.

Reactivity:

Hu, Mu, Rt, Po, Bv

Species Glossary

Reactivity: Hu, Mu, Rt, Po, Bv

Applications:

, , ,

Applications: , , ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Conjugate:

PE

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	NBP1-21502AF350
Alexa Fluor 405	NBP1-21502AF405
Alexa Fluor 488	NBP1-21502AF488
Alexa Fluor 532	NBP1-21502AF532
Alexa Fluor 594	NBP1-21502AF594
Alexa Fluor 647	NBP1-21502AF647
Alexa Fluor 700	NBP1-21502AF700
Alexa Fluor 750	NBP1-21502AF750
Allophycocyanin	NBP1-21502APC
Allophycocyanin/Cy7	NBP1-21502APCCY7
Biotin	NBP1-21502B
DyLight 350	NBP1-21502UV
DyLight 405	NBP1-21502V
DyLight 488	NBP1-21502G
DyLight 550	NBP1-21502R
DyLight 594	NBP1-21502DL594
DyLight 650	NBP1-21502C
DyLight 680	NBP1-21502FR
DyLight 755	NBP1-21502IR
FITC	NBP1-21502F
HRP	NBP1-21502H
Janelia Fluor 549	NBP1-21502JF549
Janelia Fluor 646	NBP1-21502JF646
PE/Atto594	NBP1-21502PEATT594
PE/Cy5.5	NBP1-21502PECY55
PE/Cy7	NBP1-21502PECY7
PerCP	NBP1-21502PCP
mFluor Violet 450 SE	NBP1-21502MFV450
mFluor Violet 500 SE	NBP1-21502MFV500
mFluor Violet 610 SE	NBP1-21502MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
BSA Free	NBP1-21502SS
BSA Free	NBP1-21502

compare

(select up to 3 products from this page to compare)

page of 1

Popular Products	Company Information	Support	Stay Connected
Antibodies Secondary Antibodies Isotype Controls Proteins and Peptides ELISA Kits Sample Size New Products	About Us Careers Novus Guarantee Contact Us Our Team	Technical Support FAQs Help Finding Antibodies Protocols

Visit our other sites

©2024 Novus Biologicals, All Rights Reserved.